Questions about our services? (USA) 877-735-3648 Outside the US: 001-610-642-6055

May 2017 Newsletter

BG control in Type 1 Diabetes Improves with Fast-Acting Insulin Aspart

According to a study published online in Diabetes Care on April 11, fast-acting insulin aspart (faster aspart) improved blood glucose control in patients with Type 1 diabetes, as compared to the conventional formulation of the drug, insulin aspart (IAsp). In the United States, insulin aspart is better known as Novo Nordisk's insulin Novolog. In many other countries, it is known as NovoRapid.

By |2017-05-18T18:17:19-04:00May 18th, 2017|Categories: May 2017 Newsletter|1 Comment

My Review of Afrezza Fast Acting Inhaled Insulin

By avoiding the need to absorb through the fat layer below the skin, Afrezza starts working almost immediately, peaks in about 15 minutes, and in most cases, clears in about 2 hours. Now that’s rapid!

Go to Top